Michael Kloth

1.5k total citations · 1 hit paper
25 papers, 701 citations indexed

About

Michael Kloth is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Michael Kloth has authored 25 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Michael Kloth's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Michael Kloth is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). Michael Kloth collaborates with scholars based in Germany, United States and United Kingdom. Michael Kloth's co-authors include Corinne M. Silva, Sarah J. Parsons, Julie L. Boerner, Jacqueline S. Biscardi, Wolfgang Goering, Wolfgang A. Schulz, Andrew D. Catling, Wilfried Roth, J. Baumgart and Hauke Lang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Michael Kloth

24 papers receiving 686 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multistain deep learning for prediction of prognosis and therapy response in colorectal cancer

2023 141 citations Sebastian Foersch, Christina Glasner et al. Nature Medicine profile →

Peers

Countries citing papers authored by Michael Kloth

Since Specialization

Citations

This map shows the geographic impact of Michael Kloth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kloth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kloth more than expected).

Fields of papers citing papers by Michael Kloth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kloth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kloth. The network helps show where Michael Kloth may publish in the future.

Co-authorship network of co-authors of Michael Kloth

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kloth. A scholar is included among the top collaborators of Michael Kloth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kloth. Michael Kloth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gene Expression Profiles of AHNAK2, DCSTAMP, FN1, and TERT Correlate With Mutational Status and Recurrence in Papillary Thyroid Carcinoma 2024 ·Genes Chromosomes and Cancer ·(unknown), (unknown), (unknown), (unknown), Mario Schindeldecker, Monika Hartmann, Michael Kloth, Arno Schad, Wilfried Roth, Thomas J. Musholt, Nils Hartmann	1
2	Decreased mitochondrial transcription factor A and mitochondrial DNA copy number promote cyclin-dependent kinase inhibitor 1A expression and reduce tumorigenic properties of colorectal cancer cells 2024 ·Discover Oncology ·(unknown), (unknown), Monika Hartmann, Hagen Roland Witzel, Michael Kloth, Wilfried Roth, Katrin E. Tagscherer, Nils Hartmann	2
3	A novel targeted NGS panel identifies numerous homologous recombination deficiency (HRD)-associated gene mutations in addition to known BRCA mutations 2024 ·Diagnostic Pathology ·(unknown), (unknown), Michael Kloth, Wilfried Roth, Nils Hartmann	7
4	Resection of Colorectal Liver Metastases with Major Vessel Involvement 2024 ·Cancers ·J. Baumgart, Sebastian Hiller, (unknown), Michael Kloth, Hauke Lang	1
5	Multistain deep learning for prediction of prognosis and therapy response in colorectal cancer breakdown → 2023 ·Nature Medicine ·Sebastian Foersch, Christina Glasner, Ann-Christin Woerl, Markus Eckstein, Daniel‐Christoph Wagner, Stefan Schulz, (unknown), Aurélie Fernandez, (unknown), Michael Kloth, Arndt Hartmann, A. Heintz, Wilko Weichert, Wilfried Roth, Carol Geppert, Jakob Nikolas Kather, Moritz Jesinghaus	141
6	Role of associating liver partition and portal vein ligation for staged hepatectomy for advanced colorectal liver disease: indispensable or overstressed? 2022 ·Minerva Surgery ·J. Baumgart, F. Bartsch, Michael Kloth, (unknown), Hauke Lang	1
7	Diffusion kernel-based predictive modeling of KRAS dependency in KRAS wild type cancer cell lines 2022 ·npj Systems Biology and Applications ·(unknown), Margarete Odenthal, Reinhard Buettner, Wilfried Roth, Michael Kloth	1
8	Cancer gene related characterization of patterns and point of recurrence after resection of colorectal liver metastases 2021 ·Annals of Translational Medicine ·Hauke Lang, J. Baumgart, Wilfried Roth, Markus Moehler, Michael Kloth	5
9	Two-Stage Hepatectomy and ALPPS for Advanced Bilateral Liver Metastases: a Tailored Approach Balancing Risk and Outcome 2019 ·Journal of Gastrointestinal Surgery ·J. Baumgart, Florian Jungmann, F. Bartsch, Michael Kloth, Jens Mittler, Stefan Heinrich, Hauke Lang	24
10	Extended Molecular Profiling Improves Stratification and Prediction of Survival After Resection of Colorectal Liver Metastases 2019 ·Annals of Surgery ·Hauke Lang, J. Baumgart, Stefan Heinrich, (unknown), (unknown), Annett Maderer, Peter R. Galle, Wilfried Roth, Michael Kloth, Markus Moehler	51
11	Exome sequencing characterizes the somatic mutation spectrum of early serrated lesions in a patient with serrated polyposis syndrome (SPS) 2017 ·Hereditary Cancer in Clinical Practice ·Sukanya Horpaopan, Jutta Kirfel, Sophia Peters, Michael Kloth, Robert Hüneburg, Janine Altmüller, Dmitriy Drichel, Margarete Odenthal, Glen Kristiansen, (unknown), Jacob Nattermann, Per Hoffmann, Peter Nürnberg, Reinhard Büttner, Hölger Thiele, Philip Kahl, Isabel Spier, Stefan Aretz	5
12	MDM2 gene amplification in esophageal carcinoma 2016 ·Oncology Reports ·(unknown), (unknown), Helen Künstlinger, (unknown), Uta Drebber, Sabine Merkelbach‐Bruse, Elfriede Bollschweiler, Michael Kloth, Wolfgang Hartmann, Arnulf H. Hölscher, Alexander Quaas, Peter Grimminger, Margarete Odenthal	17
13	Molecular and Clinical Evidence for anARMC5Tumor Syndrome: Concurrent Inactivating Germline and Somatic Mutations Are Associated With Both Primary Macronodular Adrenal Hyperplasia and Meningioma 2014 ·The Journal of Clinical Endocrinology & Metabolism ·Ulf Elbelt, Alessia Trovato, Michael Kloth, Enno Gentz, R. Finke, Joachim Spranger, David J. Galas, Susanne N. Weber, (unknown), Katharina König, Wiebke Arlt, Reinhard Büttner, Patrick May, Bruno Allolio, Jochen G. Schneider	73
14	Changing Histopathological Diagnostics by Genome-Based Tumor Classification 2014 ·Genes ·Michael Kloth, Reinhard Buettner	10
15	DNA Methylation Changes in Prostate Cancer 2012 ·Methods in molecular biology ·Wolfgang Goering, Michael Kloth, Wolfgang A. Schulz	50
16	STAT5b, a Mediator of Synergism between c-Src and the Epidermal Growth Factor Receptor 2003 ·Journal of Biological Chemistry ·Michael Kloth, (unknown), Jacqueline S. Biscardi, Julie L. Boerner, Sarah J. Parsons, Corinne M. Silva	132
17	Intracellular signaling by growth hormone variant (GH-V) 2002 ·Growth Hormone & IGF Research ·Corinne M. Silva, Michael Kloth, Charles E. Lyons, (unknown), Susan E. Kirk	12
18	Novel Activation of STAT5b in Response to Epidermal Growth Factor 2002 ·Journal of Biological Chemistry ·Michael Kloth, Andrew D. Catling, Corinne M. Silva	54
19	Immune Response to Non-O157 Vero Toxin--Producing Escherichia coli in Patients with Hemolytic Uremic Syndrome 1996 ·The Journal of Infectious Diseases ·Kerstin U. Ludwig, Martin Bitzan, Stefan Zimmermann, Michael Kloth, H. Ruder, D. E. Müller‐Wiefel	49
20	Expression of N-acetyltransferase (NAT) in cultured human uroepithelial cells 1994 ·Carcinogenesis ·Michael Kloth, (unknown), Edward M. Messing, S. Swaminathan	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact